#ESCcongress 2025 #abstract “#CAD in the LAD was associated with a greater likelihood of causing ischemia compared with the RCA and LCX. Independently from plaque burden and average lumen area, non-obstructive CAD in the LAD had 4 times more ischemia than the other vessels, with

#ESCcongress 2025 #abstract I thought that the abstract was submitted to the wrong meeting… “#Achilles tendon (AT) thickening is a key clinical feature of familial hypercholesterolemia (FH). Although soft X-ray radiography (XR) are widely used for AT thickness (ATT)

#CRT2026 Looking forward to seeing you in #Washington DC in 2026! Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting Georgetown/WHC Cardiology Fellows

#ESCcongress 2025 #REBOOT trial No benefit using beta blockers post #AMI. nejm.org TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting Georgetown/WHC Cardiology Fellows PCRonline 🫀

#ESCcongress 2025 #BETAMI DANBLOCK trial Opposite results…! GREAT benefit using beta blockers post #AMI in patients with preserved EF nejm.org TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting Georgetown/WHC Cardiology Fellows

#ESCcongress 2025 #BETAMI DANBLOCK, CAPITAL & #REBOOT meta analysis GREAT benefit using beta blockers post #AMI in patients with mildly (40-49%) reduced EF thelancet.com/journals/lance… TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo

#ESCcongress 2025 #abstract “Pharmacological pre-treatment for #STEMI & #NSTEMI” Nice summary by Prof. Gilles which is at odds with with Guidelines recommendations for STEMI TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting

#ESCcongress 2025 #baxdrostat In a broader perspective, there will be fewer patients for #renaldenervation? I would welcome a RCT in mild/moderate #HTN with baxdrostat as monotherapy nejm.org TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta

#ESCcongress 2025 #abstract “Popcorn type #calcification by #CCTA was a strong predictor of #CN by #OCT/OFDI.” TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting Georgetown/WHC Cardiology Fellows PCRonline 🫀

#ESCcongress 2025 #abstract “Targeted medical treatment based on specific endotype defined by intracoronary #physiology testing leads to rapid improvement of quality of life in symptomatic patients with #INOCA” Targeted? It seems that BB and CCB work for both... TCTMD

#ESCcongress 2025 #abstract “DL-model for fully automated and precise segmentation of cardiac substructures in 3D #CT images. It enables rapid, consistent segmentation and extraction of quantitative metrics. The model is openly accessible, supporting future research in cardiac

#ESCcongress 2025 #neomindset trial “In #ACS patients, monotherapy (stopping ASA early) failed to be non inferior to #DAPT… although bleeding was much less I the former” nejm.org TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo

#ESCcongress 2025 #changetheguidelines In ACS patients, DAPT for 12 months is not supported by the current (evolving) evidence TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting Georgetown/WHC Cardiology Fellows PCRonline 🫀

#ESCcongress 2025 #targetfirst trial “In #AMI patients, monotherapy (stopping ASA early) SUSCCEEDED to be non inferior to #DAPT” nejm.org/doi/full/10.10… TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting Georgetown/WHC Cardiology Fellows PCRonline 🫀

#ESCcongress 2025 #newtonCABG #evolocumab and #SVG patency: this drug did not show improved patency compared to placebo thelancet.com/journals/lance… TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting Georgetown/WHC Cardiology Fellows PCRonline 🫀

#ESCcongress 2025 #TACSI trial #DAPT (ticagrelor + ASA) or #SAPT after #CABG? “DAPT did not show superiority in reducing MACE after CABG compared to SAPT” Was the lack of benefit related to the very high rate of discontinuation of #DAPT due to bleeding, dyspnea and need to

#ESCcongress 2025 #TOPCABG trial #Descalation (after 1-3mos) of #DAPT following #CABG? “Descalation of #DAPT show superiority compared to #DAPT for 12 mos in reducing #SVG occlusion after CABG” Bleeding is also lower in De-DAPT... TCTMD TCT Conference Hector Garcia Luis Ortega Paz

#ESCcongress 2025 #OPINION trial #Prophylactic #Surgical LAAO in non #AFib but with high #CHA2DS2? No, OPINION study results do not support this strategy academic.oup.com/eurheartj/issu… TCTMD TCT Conference Hector Garcia Luis Ortega Paz Jorge Sanz Sánchez Salvatore Brugaletta Nieves Gonzalo CRT Meeting